Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-17-1176
Full Text
Open PDFAbstract
Available in full text
Date
June 15, 2018
Authors
Publisher
American Association for Cancer Research (AACR)